Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Taiwan
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Chunghwa Chemical Synthesis & Biotech Co Ltd

+ Add to Watchlist

1762:TT

33.70 TWD 0.65 1.97%

As of 02:38:15 ET on 05/29/2015.

Snapshot for Chunghwa Chemical Synthesis & Biotech Co Ltd (1762)

Open: 33.10 Day's Range: 32.85 - 34.35 Volume: 594,100
Previous Close: 33.05 52wk Range: 30.70 - 47.45 1-Yr Rtn: -22.30%

Stock Chart for 1762

No chart data available.
  • 1762:TT 33.70
  • 1D
  • 1M
  • 1Y
33.05
Interactive 1762 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 1762

Current P/E Ratio (ttm) 12.8376
Estimated P/E(12/2015) 8.7990
Relative P/E vs. TWSE -
Earnings Per Share (TWD) (ttm) 2.6251
Est. EPS (TWD) (12/2015) 3.8300
Est. PEG Ratio -
Market Cap (M TWD) 2,613.77
Shares Outstanding (M) 77.56
30 Day Average Volume 438,544
Price/Book (mrq) 1.4753
Price/Sale (ttm) 2.7659
Dividend Indicated Gross Yield 1.48%
Cash Dividend (TWD) 0.5000
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 1762

  • Revenue
  • Net Income (M/TWD)
  • Profit Margin (%)

Company Profile & Key Executives for 1762

Chunghwa Chemical Synthesis & Biotech Co Ltd is a biomedical company. The Company contract manufactures a wide range of pharmaceutical products, including pain management, antifungal, immunosuppressant, as well as provides synthesis and biotechnology technologies.

Wang Hsun-ShengChairmanChang Hsiang-HanPresident
Huang Chung-HsinVP:BusinessTsai Chi-FengVP:Engineering
More Company Profile & Key Executives for 1762

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil